
Investors
INVEST IN THE FUTURE OF MEDICATION SAFETY
WITH SONONURSE — TOOLS TO SAVE LIVES, ANYWHERE
We’re commercializing our flagship product, DVI-Stat, to address one of the most overlooked but deadly problems in healthcare.
WHY NOW
THE CRISIS: MEDICATION ERRORS AT BEDSIDE
-
1 in 2 surgeries involves a medication error (WHO)
-
23.5% of incidents in Quebec hospitals are drug related
-
IV medication prep often relies on manual double checks and no real-time safeguards
-
Bedside environments are high-pressure and error-prone — but under-supported
Healthcare workers deserve better tools - ad patients deserve safer outcomes.
_Configuration_iso%201.png)
OUR SOLUTION
MEET DVI-STAT: OUR FAST, PORTABLE, AND DESIGNED FOR SAFETY
A compact, camera-based device that scans IV drug labels in real-time, DVI-Stat instantly detects potential medication risks.
No Wi-Fi, no integration — just simple, life-saving automation.
-
Instant label scanning
-
Audio/visual alerts for wrong drug or expired dose
-
Plug-and-play setup
“It’s like having a second set of eyes — without slowing down care.”
-
One-person double-checking workflow
-
Built with frontline clinicians
WHERE WE ARE NOW
DEVELOPMENT STAGE & TRACTION
-
Technology Readiness Level: 7-8
-
Working prototype tested in simulated clinical settings
-
Clinical interest from Quebec ER teams
-
Multidisciplinary team across engineering, clinical operations, and design
Healthcare workers deserve better tools - and patients deserve safer outcomes.
MEET THE TEAM
Join Our Mission to Make Healthcare Safer.




Why Invest in Sononurse
The Problem:
In fast-paced, high-risk clinical environments, healthcare professionals lack the accessible, real-time tools they need to deliver safe, standardized care.
The Opportunity:
Sononurse develops intuitive, plug-and-play clinical tools that reduce medical errors, accelerate procedures, and support training — all without disrupting workflows.
The Market:
The global patient safety and point-of-care device market is projected to exceed $50B+. We’re targeting emergency departments, rural clinics, mobile care teams, and frontline training institutions.
Build by Clinicians, for Clinicians:
Sononurse is founded by frontline healthcare professionals who understand the challenges from inside the system. Every product is rooted in real clinical experience — designed to solve what we’ve lived through.
We’re not guessing what clinicians need. We’ve lived it — and we’re building the tools we wish we had.
Milestones & Traction
-
Incorporated in 2022
-
Accepted into Centech and supported by TransMedTech
-
Grants and clinical guidance from top medical networks
-
Strong interest from hospitals and clinician-led pilot programs
-
IP strategy in development (patent pending DVI-Stat)
Some Of Our Solutions
DVI-Stat – Smart IV medication verification
-
Prevents dosage errors with real-time scanning
-
Tracks expiration dates and interaction risks
Install-VASC – Enhanced vascular access tool
-
Improves needle placement with ultrasound-guided support
-
One-handed control, faster catheterization, fewer complications
SonoVR/AR – Immersive clinical training
-
Portable and scalable training on high-risk procedures
-
Designed for nurses, paramedics, and new grads
Our Funding Focus
-
We're raising capital to expand our clinical reach, accelerate product development, and prepare for global market entry.
This round will support:
-
U.S. market expansion, including FDA clearance and reimbursement pathway development
-
EMR integration and workflow automation in urgent care settings
-
Adaptation of our devices for medical transport and prehospital environments
-
Implementation of ISO 13485 to meet international regulatory standards
-
Product enhancements based on clinical feedback
-
Strategic hires in engineering, regulatory affairs, and commercialization
-
If you're aligned with our mission to bring safer, smarter care to the front lines — we’d love to connect.
Ready to Learn More?
Download our investor deck, or book a discovery call with our founding team.
contact@sononurse.com
www.sononurse.com/investors
What Our Partners Say

